This study summarizes the personalized diagnosis, treatment, and nursing process of a patient with toxic epidermal necrolysis (TEN) caused by exposure to S,S-dimethyl cyanoimidodithiocarbonate (DCT). Key treatment regimens include systemic glucocorticoids, cyclosporine, intravenous immunoglobulin, and single-dose infliximab, combined with nursing care for impaired skin and mucosal integrity, multidisciplinary pain management, and supportive therapy. The patient had approximately 60% body surface area (BSA) involvement upon admission. After 20 days of intensive treatment and personalized nursing, the patient’s skin lesions had nearly healed, and the condition improved sufficiently to allow discharge.
Liu et al. (Thu,) studied this question.